Certified by Founder
Lodge
BioLoomics, Inc.
start up
United States
- Boulder, CO
- 20/09/2023
- Seed
- $8,700,000
BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create target degrading antibodies. Our proprietary tech combines single-cell bioassay engineering, robotics, and ML.
#synbio #directedevolution #antibodies
- Industry Biotechnology Research
- Website https://www.bioloomics.com/
- LinkedIn https://www.linkedin.com/company/bioloomics/about/